• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    180.36 Down 2.40(1.31%) 4:00PM EST
    |After Hours : 180.43 Up 0.15 (0.08%) 4:09PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:182.76
    Open:179.70
    Bid:171.50 x 100
    Ask:182.56 x 600
    1y Target Est:210.59
    Beta:1.45
    Next Earnings Date:29-Jan-15ALXN Earnings announcement
    Day's Range:178.79 - 182.78
    52wk Range:128.89 - 203.30
    Volume:765,707
    Avg Vol (3m):1,114,410
    Market Cap:35.76B
    P/E (ttm):75.02
    EPS (ttm):2.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):30.52
    P/S (ttm):17.45
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :5.20
    Quarterly EPS Est (Dec-14) :1.29
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback